Digoxin Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 62.5 mcg, 125 mcg, 250 mcg

Reference Brands: Lanoxin(US & EU)

Category: Critical Care

Digoxin is a key cardiac drug for heart failure and atrial fibrillation, available as oral tablets, oral solution, and 250 mcg/mL IV injection. Brands include Lanoxin and Digoxin Hameln. It is widely supplied to hospitals and clinics via pharma B2B procurement networks and institutional cardiac care supply chains. Digoxin is available in Tablets and strengths such as 62.5 mcg, 125 mcg, 250 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Digoxin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Digoxin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Digoxin is a cardiac glycoside used in the treatment of heart failure and atrial fibrillation. It enhances myocardial contractility while controlling ventricular rate by inhibiting the sodium-potassium ATPase pump. Available in oral tablets (62.5, 125, and 250 mcg), oral solution (50 mcg/mL), and IV injection (250 mcg/mL), Digoxin is widely used in both acute and chronic cardiac care. In the US, Lanoxin and Pfizer’s generic injections are common, while EU brands include Lanoxin, Digoxin Hameln, and Meda. Hospitals, cardiology centers, and clinics procure Digoxin regularly through pharma B2B platforms and hospital group purchasing organizations.